No.9
公告
2026/11/03 21:04
開示要取引
DISCLOSEABLE TRANSACTION PARTICIPATION IN THE ESTABLISHMENT OF AN INVESTMENT FUND
📄 開啟公告原文
刪除
No.8
公告
2026/10/30 09:15
その他
VOLUNTARY ANNOUNCEMENT ON-MARKET SHARE REPURCHASE
📄 開啟公告原文
刪除
No.7
公告
2026/10/29 21:00
株式報酬制度
GRANT OF RESTRICTED SHARE UNITS
📄 開啟公告原文
刪除
No.6
公告
2026/10/27 09:15
事業の狀況
VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE REPORTS PRELIMINARY POSITIVE FIRST-IN-HUMAN CLINICAL TRIAL DATA FOR ISM6331 DESIGNED USING GENERATIVE AI IN MESOTHELIOMA AND OTHER SOLID TUMORS AT ESMO 2026
📄 開啟公告原文
刪除
No.5
公告
2026/10/20 09:15
事業の狀況
VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE TRIGGERS A MILESTONE PAYMENT IN AI-DRIVEN R&D COLLABORATION WITH SERVIER FOR ACHIEVING EARLY DRUG DISCOVERY MILESTONE
📄 開啟公告原文
刪除
No.4
公告
2026/10/13 09:15
事業の狀況
VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE NOMINATES PERIPHERAL-RESTRICTED VAV1 MOLECULAR GLUE DEGRADER FOR POTENTIAL TREATMENT OF AUTOIMMUNE DISEASES
📄 開啟公告原文
刪除
No.3
公告
2026/09/30 13:15
事業の狀況
VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE NOMINATES NEXT-GENERATION SMALL MOLECULE GIPR ANTAGONIST FOR POTENTIAL INTERVENTION OF OBESITY AND RELATED DISORDERS
📄 開啟公告原文
刪除
No.2
公告
2026/09/21 13:26
事業の狀況
VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE ENTERED INTO AN AI CO-DEVELOPMENT COLLABORATION WITH A CONTRACT VALUE UP TO TENS OF MILLIONS OF U.S. DOLLARS TO BUILD AND COMMERCIALIZE FOUNDATION MODELS FOR BIOLOGY
📄 開啟公告原文
刪除
No.1
公告
2026/09/14 09:00
その他
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD
📄 開啟公告原文
刪除